HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS - ANVISA Registration 10287410960

Access comprehensive regulatory information for HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10287410960 and manufactured by manufacturer not specified. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until Sep 19, 2026.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including ABBOTT IRELAND DIAGNOSTIC DIVISION, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.